OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
ONCS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
FLGTFulgent Genetics, Inc. -1.45%101.260.7%$209.40m
NVTAInvitae Corp. 0.93%40.171.3%$153.33m
GHGuardant Health, Inc. -1.52%147.180.0%$149.97m
DVADaVita, Inc. 0.09%102.233.6%$106.77m
NTRANatera, Inc. 6.74%116.091.2%$87.36m
SDCSmileDirectClub, Inc. -1.36%11.600.0%$81.02m
ONEM1Life Healthcare, Inc. -2.24%47.510.0%$65.66m
OSHOak Street Health, Inc. -4.23%53.020.0%$61.57m
NVOSNovo Integrated Sciences, Inc. -16.64%5.210.0%$47.34m
CHEChemed Corp. 0.02%446.4410.1%$42.96m
NEONeoGenomics, Inc. 0.22%50.975.5%$40.82m
AMEDAmedisys, Inc. -3.54%253.6411.3%$37.71m
ACHCAcadia Healthcare Co., Inc. 7.56%55.2427.1%$35.87m
LHCGLHC Group, Inc. -3.40%181.712.9%$31.17m
OPCHOption Care Health, Inc. 1.91%19.190.0%$27.75m

Company Profile

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.